Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Recommendation of “Reduce” from Analysts

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have received an average rating of “Reduce” from the ten ratings firms that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation, one has assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $3.5214.

A number of equities analysts have recently commented on the company. Wall Street Zen raised Definitive Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, March 14th. Morgan Stanley reaffirmed an “underperform” rating and issued a $3.50 target price on shares of Definitive Healthcare in a report on Thursday, December 18th. Barclays lowered their price target on shares of Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating for the company in a report on Monday, December 8th. Canaccord Genuity Group dropped their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating on the stock in a research report on Friday, February 27th. Finally, Zacks Research lowered shares of Definitive Healthcare from a “hold” rating to a “strong sell” rating in a report on Thursday, March 5th.

Institutional Trading of Definitive Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. New York State Common Retirement Fund boosted its stake in shares of Definitive Healthcare by 0.4% during the second quarter. New York State Common Retirement Fund now owns 766,433 shares of the company’s stock worth $2,989,000 after buying an additional 3,066 shares during the period. BNP Paribas Financial Markets increased its position in Definitive Healthcare by 32.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 17,811 shares of the company’s stock valued at $72,000 after acquiring an additional 4,407 shares during the period. State of Alaska Department of Revenue raised its stake in Definitive Healthcare by 109.3% during the 4th quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock valued at $32,000 after acquiring an additional 5,970 shares during the last quarter. Invesco Ltd. raised its stake in Definitive Healthcare by 5.8% during the 4th quarter. Invesco Ltd. now owns 117,427 shares of the company’s stock valued at $337,000 after acquiring an additional 6,400 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Definitive Healthcare during the 2nd quarter worth approximately $32,000. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Price Performance

Shares of NASDAQ DH opened at $1.05 on Tuesday. The stock’s 50-day moving average is $1.61 and its two-hundred day moving average is $2.48. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.64 and a quick ratio of 1.64. Definitive Healthcare has a 1-year low of $0.97 and a 1-year high of $4.70. The company has a market cap of $109.69 million, a price-to-earnings ratio of -0.84 and a beta of 1.66.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.